High Tech Pharm Co., Ltd. (106190.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩8,880 (+0.00%) as of
Key statistics
- Market cap
- 94.42B
- Dividend yield
- 1.69%
- 52-week range
- 8,520.00 – 25,000.00
- Beta
- 0.04
- Revenue (TTM)
- 69.41B
- Profit margin
- 17.18%
- Volume
- 27.55k
About High Tech Pharm Co., Ltd.
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Chungju-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.